Sientra, Inc. is a medical aesthetics company. The company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 150 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. The Company offers a range of breast implants, including anatomically-shaped textured, round textured and round smooth. It also offers a line of breast tissue expanders, most of which are marketed as ACX, in 25 different shapes and sizes that include single and double chamber tissue expanders. In addition, it offers a range of other aesthetic products, including: body contouring and other implants; silicone elastomer oval carving blocks; scar management specialty products; temporary, single-use, saline-filled breast sizers, and non-breast tissue expanders.
Company Growth (employees)
Goleta, US
Size (employees)
96 (est)
Sientra is headquartered in Goleta, US

Key People at Sientra

Jason O'Hearn

Jason O'Hearn

Vice President of Sales
Joann Kuhne

Joann Kuhne

Vice President Regulatory Affairs and Quality Assurance
Dan Carlisle

Dan Carlisle

Vice President of Product Technology and Manufacturing
Deborah Bettencourt

Deborah Bettencourt

Vice President, Corporate Administration
Rosalyn D'incelli

Rosalyn D'incelli

Vice President, Clinical Operations

Sientra Office Locations

Sientra has an office in Goleta
Goleta, US (HQ)
200 420 S Fairview Ave

Sientra Data and Metrics

Sientra Financial Metrics

Sientra's revenue was reported to be $20.7 m in FY, 2016 which is a 46% decrease from the previous period.

Revenue (FY, 2016)

20.7 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

13.9 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(40.2 m)

EBIT (FY, 2016)

(40 m)

Market capitalization (27-Jun-2017)

179.9 m

Closing share price (27-Jun-2017)


Cash (31-Dec-2016)

67.2 m
Sientra's current market capitalization is $179.9 m.
USDFY, 2014FY, 2015FY, 2016


44.7 m38.1 m20.7 m

Revenue growth, %


Cost of goods sold

11.5 m10.7 m6.9 m

Gross profit

33.2 m27.5 m13.9 m

Gross profit Margin, %


Sales and marketing expense

23.6 m25.8 m20.6 m

R&D expense

4.7 m7.2 m9.7 m

General and administrative expense

10.7 m18.7 m23.6 m

Operating expense total

39 m66 m53.9 m


(5.8 m)(38.5 m)(40 m)

EBIT margin, %


Interest expense

(2.2 m)(3.1 m)(98 k)

Interest income

32 k63 k

Pre tax profit

(5.8 m)(41.2 m)(40.1 m)

Income tax expense

61 k

Net Income

(5.8 m)(41.2 m)(40.2 m)
USDFY, 2014FY, 2015FY, 2016


96.7 m112.8 m67.2 m

Accounts Receivable

7.4 m8.2 m11.8 m


1.8 m1.5 m1.9 m

Current Assets

123.9 m139.1 m100 m


555 k1.4 m3 m


14.3 m14.3 m4.9 m

Total Assets

139.1 m140.8 m114.3 m

Accounts Payable

2.6 m4.1 m3.6 m

Total Debt

25.4 m25.4 m

Current Liabilities

20.7 m20.5 m27.5 m

Additional Paid-in Capital

229.8 m294.2 m299.1 m

Retained Earnings

(134 m)(175.3 m)(215.4 m)

Total Equity

95.6 m118.9 m83.6 m

Debt to Equity Ratio

0.3 x0.2 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.5 x1.2 x1.4 x
USDFY, 2014FY, 2015FY, 2016

Net Income

(5.8 m)(41.2 m)(40.2 m)

Depreciation and Amortization

275 k318 k1.2 m

Accounts Receivable

(873 k)715 k927 k


1.4 m(898 k)2.4 m

Accounts Payable

(2.3 m)1.5 m(564 k)

Cash From Operating Activities

87 m16.1 m(34.4 m)

Purchases of PP&E

(439 k)(1.1 m)(1.1 m)

Cash From Investing Activities

(439 k)(1.1 m)(12.8 m)

Long-term Borrowings

(26.6 m)(26.6 m)

Cash From Financing Activities

87 m35.4 m1.7 m

Interest Paid

1.6 m1.9 m96 k
Y, 2016

Financial Leverage

1.4 x

Sientra Market Value History

Sientra Company Life and Culture

You may also be interested in